Total Payments
$13,599
2024 Payments
$1,738
Companies
56
Transactions
915
Medicare Patients
8,549
Medicare Billing
$357,517
Payment Breakdown by Category
Food & Beverage$13,392 (98.5%)
Education$207.46 (1.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,392 | 908 | 98.5% |
| Education | $207.46 | 7 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,663 | 131 | $0 (2024) |
| ABBVIE INC. | $1,510 | 112 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,154 | 56 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,138 | 74 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,073 | 83 | $0 (2024) |
| Amgen Inc. | $874.49 | 64 | $0 (2022) |
| Lilly USA, LLC | $619.89 | 47 | $0 (2024) |
| PFIZER INC. | $574.73 | 38 | $0 (2024) |
| Allergan, Inc. | $452.48 | 40 | $0 (2020) |
| Astellas Pharma US Inc | $369.09 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,738 | 103 | ABBVIE INC. ($400.86) |
| 2023 | $1,884 | 111 | AbbVie Inc. ($406.75) |
| 2022 | $2,187 | 141 | ABBVIE INC. ($322.34) |
| 2021 | $1,880 | 146 | Boehringer Ingelheim Pharmaceuticals, Inc. ($376.90) |
| 2020 | $1,471 | 104 | Novo Nordisk Inc ($281.46) |
| 2019 | $1,421 | 105 | Novo Nordisk Inc ($253.01) |
| 2018 | $1,495 | 104 | GlaxoSmithKline, LLC. ($193.97) |
| 2017 | $1,523 | 101 | AstraZeneca Pharmaceuticals LP ($160.26) |
All Payment Transactions
915 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: PAIN | ||||||
| 12/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: VACCINES | ||||||
| 12/12/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.09 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.04 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $44.23 | General |
| Category: Medical Device | ||||||
| 11/21/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: ANTIBIOTIC | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Gastroenterology | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/11/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.59 | General |
| Category: Cardiovascular | ||||||
| 11/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Obesity | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Obesity | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: ANTIBIOTIC | ||||||
| 10/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,346 | 3,808 | $251,898 | $91,751 |
| 2022 | 33 | 2,016 | 3,470 | $236,788 | $88,115 |
| 2021 | 35 | 2,064 | 3,532 | $235,681 | $90,546 |
| 2020 | 31 | 2,123 | 3,547 | $242,586 | $87,105 |
Total Patients
8,549
Total Services
14,357
Medicare Billing
$357,517
Procedure Codes
131
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 269 | 535 | $123,050 | $39,098 | 31.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 255 | 447 | $14,304 | $5,762 | 40.3% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 256 | 467 | $9,807 | $4,771 | 48.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 103 | $16,274 | $4,653 | 28.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 263 | 561 | $7,696 | $4,541 | 59.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $6,201 | $3,415 | 55.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 30 | 30 | $9,900 | $3,220 | 32.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 137 | 192 | $7,680 | $3,144 | 40.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 46 | 46 | $3,404 | $3,118 | 91.6% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 59 | 59 | $4,720 | $2,680 | 56.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 156 | 279 | $6,417 | $2,628 | 40.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 199 | 270 | $5,130 | $2,019 | 39.4% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 16 | 16 | $6,032 | $1,927 | 31.9% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 76 | 76 | $3,268 | $1,438 | 44.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $2,209 | $1,280 | 57.9% |
| 82306 | Vitamin d-3 level | Office | 2023 | 31 | 43 | $2,967 | $1,247 | 42.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 19 | 37 | $4,736 | $1,233 | 26.0% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 42 | 50 | $2,150 | $846.94 | 39.4% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 13 | 27 | $1,647 | $657.54 | 39.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 33 | 85 | $4,930 | $580.16 | 11.8% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 16 | 16 | $1,840 | $568.95 | 30.9% |
| 84466 | Transferrin (iron binding protein) level | Office | 2023 | 25 | 37 | $1,110 | $445.03 | 40.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 22 | 28 | $1,008 | $413.84 | 41.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 29 | 78 | $624.00 | $387.22 | 62.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $611.00 | $341.28 | 55.9% |
About Dr. Patrick Collins, D.O
Dr. Patrick Collins, D.O is a Family Medicine healthcare provider based in Sevierville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629043476.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Collins, D.O has received a total of $13,599 in payments from pharmaceutical and medical device companies, with $1,738 received in 2024. These payments were reported across 915 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($13,392).
As a Medicare-enrolled provider, Collins has provided services to 8,549 Medicare beneficiaries, totaling 14,357 services with total Medicare billing of $357,517. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Sevierville, TN
- Active Since 02/22/2006
- Last Updated 07/25/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1629043476
Products in Payments
- VRAYLAR (Drug) $906.42
- FARXIGA (Drug) $881.87
- Ozempic (Drug) $800.27
- TRELEGY ELLIPTA (Drug) $678.11
- JARDIANCE (Drug) $590.53
- ELIQUIS (Drug) $460.48
- UBRELVY (Drug) $455.64
- XIFAXAN (Drug) $404.85
- NURTEC ODT (Drug) $345.06
- Vascepa (Drug) $331.30
- Rybelsus (Drug) $324.11
- Aimovig (Biological) $312.93
- STIOLTO RESPIMAT (Drug) $305.14
- EVENITY (Biological) $279.62
- TRULICITY (Drug) $255.40
- GEMTESA (Drug) $240.49
- Prolia (Biological) $188.77
- SYMBICORT (Drug) $171.15
- QULIPTA (Drug) $164.96
- MOUNJARO (Drug) $164.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Sevierville
Dr. Amy Gust, M.d, M.D
Family Medicine — Payments: $13,988
Family Medicine $13,988
Candice Drewry, Md, MD
Family Medicine — Payments: $12,450
Family Medicine $12,450
Charles Bozeman, Md, MD
Family Medicine — Payments: $8,549
Family Medicine $8,549
Dr. Kenneth Justice, Md, MD
Family Medicine — Payments: $4,519
Family Medicine $4,519
Dr. Keri Melancon, Md, MD
Family Medicine — Payments: $3,382
Family Medicine $3,382
Kristie Young, Do, DO
Family Medicine — Payments: $3,370
Family Medicine $3,370